ISSUE 85 I AUGUST 2019

Taming the

pharma beast

How can Big Pharma move the industry away from patents to become more patient-focused?

In association with

02/23/2024 22:41:03

07/29/2019 00:00:00

Go to article: Home | Taming the pharma beast Go to article: In this issue Go to article: Emirates SkyCargo Go to article: Contents Go to article: TSS Company Insight Go to article: News Go to article: Daiichi Jitsugyo Go to article: ICCI Company Insight Go to article: ICCI Go to article: The pharma industry briefing Go to article: Novo Nordisk Go to article: Swiss WorldCargo Go to article: Understanding drug-resistant TB Go to article: CBDepot Company Insight Go to article: CBDepot Go to article: Through time: the breakthroughs that changed the course of HIV treatment Go to article: Senn Chemicals Go to article: Qatar Airways Go to article: Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woes Go to article: Accurate Biometrics Company Insight Go to article: Accurate Biometrics Go to article: The dangers of unlicensed stem cell clinics Go to article: Komtur Pharmaceuticals Go to article: How do cancer cells communicate and can it help us catch them?Go to article: Verona’s ensifentrine: a potentially revolutionary treatment for COPD Go to article: Taming the pharma monster with Hedley Rees Go to article: Capsugel Company Insight Go to article: Altheria Solutions Go to article: ‘Pay As You Go’ AI for drug discovery Go to article: AtoZ-CRO GmbH Go to article: PharmaHemp Go to article: Event: CPhl Korea Go to article: Events Go to article: Centaur Clinical | Company Insight Go to article: Centaur Clinical Go to article: Next issue Go to article: Hapa Company Insight Go to article: Pfanstiehl